289 related articles for article (PubMed ID: 29280974)
21. Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.
Kim S; Lalani S; Parekh VV; Wu L; Van Kaer L
Expert Rev Vaccines; 2008 Dec; 7(10):1519-32. PubMed ID: 19053208
[TBL] [Abstract][Full Text] [Related]
22. Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model.
Renukaradhya GJ; Manickam C; Khatri M; Rauf A; Li X; Tsuji M; Rajashekara G; Dwivedi V
J Clin Immunol; 2011 Apr; 31(2):228-39. PubMed ID: 21042929
[TBL] [Abstract][Full Text] [Related]
23. Targeted disruption of CD1d prevents NKT cell development in pigs.
Yang G; Artiaga BL; Hackmann TJ; Samuel MS; Walters EM; Salek-Ardakani S; Driver JP
Mamm Genome; 2015 Jun; 26(5-6):264-70. PubMed ID: 25930071
[TBL] [Abstract][Full Text] [Related]
24. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
25. Harnessing invariant NKT cells in vaccination strategies.
Cerundolo V; Silk JD; Masri SH; Salio M
Nat Rev Immunol; 2009 Jan; 9(1):28-38. PubMed ID: 19079136
[TBL] [Abstract][Full Text] [Related]
26. New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand.
Moise L; Gutiérrez AH; Khan S; Tan S; Ardito M; Martin WD; De Groot AS
Front Immunol; 2020; 11():563362. PubMed ID: 33123135
[TBL] [Abstract][Full Text] [Related]
27. Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide.
Gu W; Madrid DMD; Yang G; Artiaga BL; Loeb JC; Castleman WL; Richt JA; Lednicky JA; Driver JP
Dev Comp Immunol; 2021 Jan; 114():103843. PubMed ID: 32871161
[TBL] [Abstract][Full Text] [Related]
28. Augmenting Influenza-Specific T Cell Memory Generation with a Natural Killer T Cell-Dependent Glycolipid-Peptide Vaccine.
Anderson RJ; Li J; Kedzierski L; Compton BJ; Hayman CM; Osmond TL; Tang CW; Farrand KJ; Koay HF; Almeida CFDSSE; Holz LR; Williams GM; Brimble MA; Wang Z; Koutsakos M; Kedzierska K; Godfrey DI; Hermans IF; Turner SJ; Painter GF
ACS Chem Biol; 2017 Nov; 12(11):2898-2905. PubMed ID: 29043774
[TBL] [Abstract][Full Text] [Related]
29. Invariant natural killer T cells: bridging innate and adaptive immunity.
Van Kaer L; Parekh VV; Wu L
Cell Tissue Res; 2011 Jan; 343(1):43-55. PubMed ID: 20734065
[TBL] [Abstract][Full Text] [Related]
30. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
31. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
Front Immunol; 2018; 9():934. PubMed ID: 29770135
[TBL] [Abstract][Full Text] [Related]
32. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.
Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901
[TBL] [Abstract][Full Text] [Related]
33. The Role of Autophagy in iNKT Cell Development.
Yang G; Driver JP; Van Kaer L
Front Immunol; 2018; 9():2653. PubMed ID: 30487800
[TBL] [Abstract][Full Text] [Related]
34. CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.
Zeissig S; Peuker K; Iyer S; Gensollen T; Dougan SK; Olszak T; Kaser A; Blumberg RS
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10449-10454. PubMed ID: 28893990
[TBL] [Abstract][Full Text] [Related]
35. Next Generation Sequencing of the Pig αβ TCR Repertoire Identifies the Porcine Invariant NKT Cell Receptor.
Yang G; Artiaga BL; Lomelino CL; Jayaprakash AD; Sachidanandam R; Mckenna R; Driver JP
J Immunol; 2019 Apr; 202(7):1981-1991. PubMed ID: 30777925
[TBL] [Abstract][Full Text] [Related]
36. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
[TBL] [Abstract][Full Text] [Related]
37. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
Papoutselis M; Spanoudakis E
Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):358-365. PubMed ID: 32234294
[TBL] [Abstract][Full Text] [Related]
38. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
[TBL] [Abstract][Full Text] [Related]
39. Antigen specificity of invariant natural killer T-cells.
Birkholz AM; Kronenberg M
Biomed J; 2015 Dec; 38(6):470-83. PubMed ID: 27013447
[TBL] [Abstract][Full Text] [Related]
40. iNKT cells in microbial immunity: recognition of microbial glycolipids.
Kinjo Y; Ueno K
Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
